The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1419
ISSUE1419
June 24, 2013
Tobramycin Inhalation Powder (Tobi Podhaler) for Cystic Fibrosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Tobramycin Inhalation Powder (Tobi Podhaler) for Cystic Fibrosis
June 24, 2013 (Issue: 1419)
Inhaled antibiotics, which can achieve high concentrations
in the lung with minimal systemic side effects, are
probably the most effective therapy available for chronic
Pseudomonas aeruginosa infection in patients with
cystic fibrosis. An orally...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.